Literature DB >> 34295711

State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies.

Balint Laczay1, Divyang Patel1, Richard Grimm1, Bo Xu1.   

Abstract

Cardiac electrophysiology procedures have evolved to provide improvement in morbidity and mortality for many patients. Cardiac resynchronization therapy (CRT), implantable cardioverter/defibrillator (ICD) placement and lead extraction procedures are proven procedures, associated with significant reductions in patient morbidity and mortality as well as improved quality of life. The applications and optimization of these therapies are an evolving field. The optimal use and outcomes of cardiac electrophysiology procedures require a multidisciplinary approach to patient selection, device selection, and procedural planning. Cardiac imaging using echocardiography plays a key role in selection of patients for CRT therapy, for guidance of left ventricular (LV) lead placement, and for optimization of atrioventricular pacing delays in patients with CRT. Cardiac computed tomography (CT) is an important tool in assessment of lead perforation, as well as assessing risk of lead extraction and procedural planning. Cardiac magnetic resonance imaging (MRI) is an important adjunct to transthoracic echocardiography for patient selection and risk stratification for defibrillator therapy for multiple disease states including ischemic cardiomyopathy, hypertrophic cardiomyopathy, cardiac sarcoidosis, and arrhythmogenic right ventricular cardiomyopathy (ARVC). Cardiac positron emission tomography (PET) is a useful adjunct to the diagnosis of device infections as well as inflammatory conditions including cardiac sarcoidosis. Our review attempts to summarize the contemporary roles of multimodality imaging in CRT therapy, ICD therapy and lead extraction therapy. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Echocardiography; cardiac magnetic resonance imaging (cardiac MRI); cardiac resynchronization therapy (CRT); implantable cardioverter/defibrillator (ICD); lead extraction; positron emission tomography/computed tomography (PET/CT); resynchronization

Year:  2021        PMID: 34295711      PMCID: PMC8261739          DOI: 10.21037/cdt-20-724

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  102 in total

Review 1.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

2.  Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John Gorcsan; Gabe B Bleeker; Qing Zhang; Martin J Schalij; Matthew S Suffoletto; Jeffrey Wing-Hong Fung; David Schwartzman; Yat-Sun Chan; Masaki Tanabe; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2007-08-20       Impact factor: 2.778

3.  Use of Preprocedural MDCT for Cardiac Implantable Electric Device Lead Extraction: Frequency of Findings That Change Management.

Authors:  Wendy L Ehieli; Daniel T Boll; Daniele Marin; Robert Lewis; Jonathan P Piccini; Lynne M Hurwitz
Journal:  AJR Am J Roentgenol       Date:  2017-01-11       Impact factor: 3.959

Review 4.  Role of echocardiography before cardiac resynchronization therapy: new advances and current developments.

Authors:  Sylvestre Marechaux; Aymeric Menet; Yves Guyomar; Pierre-Vladimir Ennezat; Raphaëlle Ashley Guerbaai; Pierre Graux; Christophe Tribouilloy
Journal:  Echocardiography       Date:  2016-08-25       Impact factor: 1.724

Review 5.  18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Authors:  Hicham Skali; Allison R Schulman; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

6.  Results of the Predictors of Response to CRT (PROSPECT) trial.

Authors:  Eugene S Chung; Angel R Leon; Luigi Tavazzi; Jing-Ping Sun; Petros Nihoyannopoulos; John Merlino; William T Abraham; Stefano Ghio; Christophe Leclercq; Jeroen J Bax; Cheuk-Man Yu; John Gorcsan; Martin St John Sutton; Johan De Sutter; Jaime Murillo
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

7.  Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.

Authors:  Andre Rudolph; Hassan Abdel-Aty; Steffen Bohl; Philipp Boyé; Anja Zagrosek; Rainer Dietz; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

Review 8.  Doppler echocardiographic methods for optimization of the atrioventricular delay during cardiac resynchronization therapy.

Authors:  Alan D Waggoner; Lisa de las Fuentes; Victor G Davila-Roman
Journal:  Echocardiography       Date:  2008-10       Impact factor: 1.724

9.  Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites.

Authors:  Nicolas Derval; Paul Steendijk; Lorne J Gula; Antoine Deplagne; Julien Laborderie; Frederic Sacher; Sebastien Knecht; Matthew Wright; Isabelle Nault; Sylvain Ploux; Philippe Ritter; Pierre Bordachar; Stephane Lafitte; Patricia Réant; George J Klein; Sanjiv M Narayan; Stephane Garrigue; Mélèze Hocini; Michel Haissaguerre; Jacques Clementy; Pierre Jaïs
Journal:  J Am Coll Cardiol       Date:  2009-11-20       Impact factor: 24.094

10.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.